Predicted Trait | |
Reported Trait | Triglyceride levels |
Mapped Trait(s) | triglyceride measurement (EFO_0004530) |
Score Construction | |
PGS Name | TG.PS |
Development Method | |
Name | Genome-wide significant SNPs |
Parameters | r2 < 0.1 |
Variants | |
Original Genome Build | NR |
Number of Variants | 108 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000418 |
Citation (link to publication) | Pieri K et al. Int J Cardiol (2022) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 237,050 individuals (100%) |
PGS Evaluation | European: 100% 2 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST009149 Europe PMC: 29083408 |
237,050 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM017030 | PSS010100| European Ancestry| 460,037 individuals |
PGP000418 | Pieri K et al. Int J Cardiol (2022) |
Reported Trait: Plasma triglyceride concentration | β: 0.142 (0.000753) | — | % change in TG (per SD PGS): 15.2 [15.0, 15.4] | — | — |
PPM017031 | PSS010099| European Ancestry| 6,952 individuals |
PGP000418 | Pieri K et al. Int J Cardiol (2022) |
Reported Trait: Plasma triglyceride concentration | β: 0.122 (0.00495) | — | % change in TG (per SD PGS): 13.0 [12.0, 14.0] | — | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010100 | — | — | 460,037 individuals, 45.7 % Male samples |
— | European | — | UKB | — |
PSS010099 | — | — | 6,952 individuals, 43.5 % Male samples |
— | European | — | OBB | — |